NUTX is expected to report earnings to fall 37.21% to $5.89 per share on November 24
Q3'26
Est.
$5.89
Q2'26
Beat
by $4.50
Q3'23
Est.
$0.00
Q2'23
Est.
$0.00
Q1'23
Est.
$-0.01
The last earnings report on August 06 showed earnings per share of $9.38, beating the estimate of $4.88. With 38.55K shares outstanding, the current market capitalization sits at 1.27B.
A.I.dvisor indicates that over the last year, NUTX has been closely correlated with SMSI. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if NUTX jumps, then SMSI could also see price increases.
The 10-day RSI Indicator for NUTX moved out of overbought territory on August 11, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 instances where the indicator moved out of the overbought zone. In of the 30 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NUTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
NUTX broke above its upper Bollinger Band on August 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for NUTX entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on August 07, 2026. You may want to consider a long position or call options on NUTX as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for NUTX just turned positive on August 10, 2026. Looking at past instances where NUTX's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
NUTX moved above its 50-day moving average on August 07, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for NUTX crossed bullishly above the 50-day moving average on August 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NUTX advanced for three days, in of 246 cases, the price rose further within the following month. The odds of a continued upward trend are .
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NUTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.228) is normal, around the industry mean (238.702). P/E Ratio (7.203) is within average values for comparable stocks, (132.211). NUTX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.747). NUTX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.014). P/S Ratio (1.565) is also within normal values, averaging (2.693).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NUTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Nutex Health (NUTX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com
